Rein Therapeutics Inc. (RNTX)

Rein Therapeutics Statistics

Total Valuation

RNTX has a market cap or net worth of $43.33 million. The enterprise value is $25.68 million.

Market Cap	43.33M
Enterprise Value	25.68M

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

RNTX has 21.67 million shares outstanding. The number of shares has increased by 201.87% in one year.

Current Share Class	21.67M
Shares Outstanding	21.67M
Shares Change (YoY)	+201.87%
Shares Change (QoQ)	+8.80%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	19.32%
Float	19.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.86
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.30

Current Ratio	3.30
Quick Ratio	3.12
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.95% and return on invested capital (ROIC) is -34.78%.

Return on Equity (ROE)	-54.95%
Return on Assets (ROA)	-31.63%
Return on Capital (ROIC)	-34.78%
Revenue Per Employee	n/a
Profits Per Employee	-$1.95M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.46% in the last 52 weeks. The beta is 2.23, so RNTX's price volatility has been higher than the market average.

Beta (5Y)	2.23
52-Week Price Change	-55.46%
50-Day Moving Average	2.50
200-Day Moving Average	3.17
Relative Strength Index (RSI)	42.77
Average Volume (20 Days)	105,098

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.62M
Pretax Income	n/a
Net Income	-29.24M
EBITDA	-29.50M
EBIT	-29.62M
Earnings Per Share (EPS)	-$2.13

Balance Sheet

Cash & Cash Equivalents	17.65M
Total Debt	n/a
Net Cash	17.65M
Net Cash Per Share	$0.81
Equity (Book Value)	95.23M
Book Value Per Share	2.32
Working Capital	13.03M

Cash Flow

Operating Cash Flow	-27.87M
Capital Expenditures	n/a
Free Cash Flow	-27.87M
FCF Per Share	-$1.29

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-201.87%
Shareholder Yield	-201.87%
Earnings Yield	-67.48%
FCF Yield	-64.32%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 11, 2022. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Nov 11, 2022
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1